324 related articles for article (PubMed ID: 32104147)
1. CD19
Chen Q; Lai L; Chi X; Lu X; Wu H; Sun J; Wu W; Cai L; Zeng X; Wang C; Chen W; Peng A
Mediators Inflamm; 2020; 2020():3019378. PubMed ID: 32104147
[TBL] [Abstract][Full Text] [Related]
2. The correlation of CD19 + CD24 + CD38 + B cells and other clinicopathological variables with the proportion of circulating Tregs in breast cancer patients.
Gheybi MK; Farrokhi S; Ravanbod MR; Ostovar A; Mehrzad V; Nematollahi P
Breast Cancer; 2017 Nov; 24(6):756-764. PubMed ID: 28429331
[TBL] [Abstract][Full Text] [Related]
3. CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation.
Flores-Borja F; Bosma A; Ng D; Reddy V; Ehrenstein MR; Isenberg DA; Mauri C
Sci Transl Med; 2013 Feb; 5(173):173ra23. PubMed ID: 23427243
[TBL] [Abstract][Full Text] [Related]
4. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.
Blair PA; Noreña LY; Flores-Borja F; Rawlings DJ; Isenberg DA; Ehrenstein MR; Mauri C
Immunity; 2010 Jan; 32(1):129-40. PubMed ID: 20079667
[TBL] [Abstract][Full Text] [Related]
5. Elevated circulating CD19
Deng B; Deng L; Liu M; Zhao Z; Huang H; Tu X; Liang E; Tian R; Wang X; Wang R; Lin H; Yu Y; Peng A; Xu P; Bao K; He M
Immunol Lett; 2023 Sep; 261():58-65. PubMed ID: 37553031
[TBL] [Abstract][Full Text] [Related]
6. PD-L1
Zacca ER; Onofrio LI; Acosta CDV; Ferrero PV; Alonso SM; Ramello MC; Mussano E; Onetti L; Cadile II; Stancich MI; Taboada Bonfanti MC; Montes CL; Acosta Rodríguez EV; Gruppi A
Front Immunol; 2018; 9():2241. PubMed ID: 30327652
[No Abstract] [Full Text] [Related]
7. Defective CD19+CD24
Cencioni MT; Ali R; Nicholas R; Muraro PA
Mult Scler; 2021 Jul; 27(8):1187-1197. PubMed ID: 32924828
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19
Zhang Y; Wei S; Wu Q; Shen X; Dai W; Zhang Z; Chen M; Huang H; Ma L
Clin Rheumatol; 2022 Aug; 41(8):2403-2416. PubMed ID: 35420296
[TBL] [Abstract][Full Text] [Related]
9. Decreased number of CD19
Li T; Yu Z; Qu Z; Zhang N; Crew R; Jiang Y
Mol Immunol; 2019 Aug; 112():233-239. PubMed ID: 31181422
[TBL] [Abstract][Full Text] [Related]
10. Decrease in the proportion of CD24
Wang Y; Qin Y; Wang X; Zhang L; Wang J; Xu X; Chen H; Hsu HT; Zhang M
Clin Exp Immunol; 2020 Apr; 200(1):22-32. PubMed ID: 31849037
[TBL] [Abstract][Full Text] [Related]
11. Peripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study.
Furuzawa-Carballeda J; Hernández-Molina G; Lima G; Rivera-Vicencio Y; Férez-Blando K; Llorente L
Arthritis Res Ther; 2013; 15(3):R68. PubMed ID: 23800367
[TBL] [Abstract][Full Text] [Related]
12. Frequency of CD19
Zhao Q; Jung LK
Pediatr Rheumatol Online J; 2018 Jul; 16(1):44. PubMed ID: 29973221
[TBL] [Abstract][Full Text] [Related]
13. Dysfunction of CD24+CD38+ B cells in patients with Hashimoto's thyroiditis is associated with a lack of interleukin 10.
Yu S; Qi Y; Wang H; Jiang J; Sun L; Zhou Q
Int J Biochem Cell Biol; 2017 Sep; 90():114-120. PubMed ID: 28827034
[TBL] [Abstract][Full Text] [Related]
14. Deficit of circulating CD19
Zaimoku Y; Patel BA; Kajigaya S; Feng X; Alemu L; Quinones Raffo D; Groarke EM; Young NS
Br J Haematol; 2020 Aug; 190(4):610-617. PubMed ID: 32311088
[TBL] [Abstract][Full Text] [Related]
15. Purification and Immunophenotypic Characterization of Human CD19
Bradford HF; Mauri C
Methods Mol Biol; 2021; 2270():77-90. PubMed ID: 33479894
[TBL] [Abstract][Full Text] [Related]
16. Decrease in proportion of CD19+ CD24(hi) CD27+ B cells and impairment of their suppressive function in Graves' disease.
Zha B; Wang L; Liu X; Liu J; Chen Z; Xu J; Sheng L; Li Y; Chu Y
PLoS One; 2012; 7(11):e49835. PubMed ID: 23189166
[TBL] [Abstract][Full Text] [Related]
17. CD24
Xu C; Zhang M; Li K; Ni M; Bai Y; Zhang J; Song X; Wang J
Int Immunopharmacol; 2019 May; 70():295-301. PubMed ID: 30851710
[TBL] [Abstract][Full Text] [Related]
18. B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjögren's syndrome: the similarities and differences.
Lin W; Jin L; Chen H; Wu Q; Fei Y; Zheng W; Wang Q; Li P; Li Y; Zhang W; Zhao Y; Zeng X; Zhang F
Arthritis Res Ther; 2014 May; 16(3):R118. PubMed ID: 24887143
[TBL] [Abstract][Full Text] [Related]
19. Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies.
Aybar LT; McGregor JG; Hogan SL; Hu Y; Mendoza CE; Brant EJ; Poulton CJ; Henderson CD; Falk RJ; Bunch DO
Clin Exp Immunol; 2015 May; 180(2):178-88. PubMed ID: 25376552
[TBL] [Abstract][Full Text] [Related]
20. An age-related numerical and functional deficit in CD19(+) CD24(hi) CD38(hi) B cells is associated with an increase in systemic autoimmunity.
Duggal NA; Upton J; Phillips AC; Sapey E; Lord JM
Aging Cell; 2013 Oct; 12(5):873-81. PubMed ID: 23755918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
